By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Asterias Biotherapeutics 

230 Constitution Drive

Menlo Park  California  94025  U.S.A.
Phone: 650-433-2992 Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Asterias Biotherapeutics Concludes Recruitment Of Initial Safety Cohort Of The SCiStar Phase 1/2a Dose-Escalation Clinical Trial Of AST-OPC1 For Complete Cervical Spinal Cord Injury 8/31/2015 6:18:06 AM
Asterias Biotherapeutics To Present At Upcoming Investor Conferences 8/28/2015 6:50:54 AM
Asterias Biotherapeutics To Present At Upcoming Investor Conferences 8/27/2015 7:03:41 AM
Asterias Biotherapeutics Reports Second Quarter Results 8/11/2015 7:51:02 AM
Asterias Biotherapeutics To Report Second Quarter Results On August 10, 2015 7/30/2015 12:39:32 PM
Asterias Biotherapeutics Added To Russell 2000, Russell 3000, Russell Global And Russell Microcap Indexes 6/30/2015 7:23:04 AM
Preliminary Reconstitutions Of Russell 3000, Russell Global And Russell Microcap Indexes Include Asterias Biotherapeutics 6/15/2015 7:42:29 AM
Asterias Biotherapeutics Announces First Patient Treated In Phase 1/2a Dose-Escalation Clinical Trial Of AST-OPC1 For Complete Cervical Spinal Cord Injury 6/8/2015 9:11:01 AM
Positive New, Long-Term Follow-Up Data Of Asterias Biotherapeutics' AST-VAC1 Cancer Vaccine Demonstrates Prolonged Relapse-Free Survival In Patients With High-Risk Acute Myelogenous Leukemia (AML) 6/1/2015 7:47:56 AM
Asterias Biotherapeutics Receives $11.7 Million In Proceeds From Exercise Of Warrants 5/26/2015 7:33:50 AM
12345
//-->